Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v10-EN
Language English English
Date Updated 2018-12-17 2018-04-24
Drug Identification Number 02278685 02278685
Brand name MIDODRINE MIDODRINE
Common or Proper name MIDODRINE MIDODRINE
Company Name APOTEX INC APOTEX INC
Ingredients MIDODRINE HYDROCHLORIDE MIDODRINE HYDROCHLORIDE
Strength(s) 5.0MG 5.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BTL 100BTL
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-26 2018-03-26
Estimated end date 2018-12-17 2018-04-18
Actual end date 2018-12-17 2018-04-23
Shortage status Actual shortage Resolved
Tier 3 Status No No
Company comments Midodrine 2.5mg is available Midodrine 2.5mg is available
Health Canada comments